110 related articles for article (PubMed ID: 24759181)
1. Acquisition of useful sero-diagnostic autoantibodies using the same patients'sera and tumor tissues.
Kobayashi M; Nagashio R; Ryuge S; Murakami Y; Yanagita K; Nakashima H; Matsumoto T; Jiang SX; Saegusa M; Satoh Y; Masuda N; Sato Y
Biomed Res; 2014; 35(2):133-43. PubMed ID: 24759181
[TBL] [Abstract][Full Text] [Related]
2. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer.
Brichory FM; Misek DE; Yim AM; Krause MC; Giordano TJ; Beer DG; Hanash SM
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9824-9. PubMed ID: 11504947
[TBL] [Abstract][Full Text] [Related]
3. Detection of tumor-specific autoantibodies in sera of patients with lung cancer.
Nagashio R; Sato Y; Jiang SX; Ryuge S; Kodera Y; Maeda T; Nakajima T
Lung Cancer; 2008 Dec; 62(3):364-73. PubMed ID: 18485524
[TBL] [Abstract][Full Text] [Related]
4. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis.
Bussone G; Dib H; Tamby MC; Broussard C; Federici C; Woimant G; Camoin L; Guillevin L; Mouthon L
Arthritis Res Ther; 2011 May; 13(3):R74. PubMed ID: 21569507
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
6. Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
Pereira-Faca SR; Kuick R; Puravs E; Zhang Q; Krasnoselsky AL; Phanstiel D; Qiu J; Misek DE; Hinderer R; Tammemagi M; Landi MT; Caporaso N; Pfeiffer R; Edelstein C; Goodman G; Barnett M; Thornquist M; Brenner D; Hanash SM
Cancer Res; 2007 Dec; 67(24):12000-6. PubMed ID: 18089831
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma.
Li Y; Li CQ; Guo SJ; Guo W; Jiang HW; Li HC; Tao SC
EBioMedicine; 2020 Mar; 53():102674. PubMed ID: 32113159
[TBL] [Abstract][Full Text] [Related]
8. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.
Brichory F; Beer D; Le Naour F; Giordano T; Hanash S
Cancer Res; 2001 Nov; 61(21):7908-12. PubMed ID: 11691811
[TBL] [Abstract][Full Text] [Related]
9. Detection of tumor-associated antigens in culture supernatants using autoantibodies in sera from patients with bladder cancer.
Minami S; Nagashio R; Ueda J; Matsumoto K; Goshima N; Hattori M; Hachimura K; Iwamura M; Sato Y
Biomed Res; 2014; 35(1):25-35. PubMed ID: 24573199
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.
Gupta P; Suman S; Mishra M; Mishra S; Srivastava N; Kumar V; Singh PK; Shukla Y
Proteomics Clin Appl; 2016 May; 10(5):564-73. PubMed ID: 27068564
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer.
Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N
Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.
Liu W; Peng B; Lu Y; Xu W; Qian W; Zhang JY
Autoimmun Rev; 2011 Apr; 10(6):331-5. PubMed ID: 21167321
[TBL] [Abstract][Full Text] [Related]
13. Calnexin is a novel sero-diagnostic marker for lung cancer.
Kobayashi M; Nagashio R; Jiang SX; Saito K; Tsuchiya B; Ryuge S; Katono K; Nakashima H; Fukuda E; Goshima N; Satoh Y; Masuda N; Saegusa M; Sato Y
Lung Cancer; 2015 Nov; 90(2):342-5. PubMed ID: 26344721
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer.
Shi L; Chevolot Y; Souteyrand E; Laurenceau E
Cancer Biomark; 2017; 18(2):105-116. PubMed ID: 27983529
[TBL] [Abstract][Full Text] [Related]
15. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
[TBL] [Abstract][Full Text] [Related]
16. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.
Tomkiel JE; Alansari H; Tang N; Virgin JB; Yang X; VandeVord P; Karvonen RL; Granda JL; Kraut MJ; Ensley JF; Fernández-Madrid F
Clin Cancer Res; 2002 Mar; 8(3):752-8. PubMed ID: 11895905
[TBL] [Abstract][Full Text] [Related]
18. Identification of specific autoantigens in Sjögren's syndrome by SEREX.
Uchida K; Akita Y; Matsuo K; Fujiwara S; Nakagawa A; Kazaoka Y; Hachiya H; Naganawa Y; Oh-Iwa I; Ohura K; Saga S; Kawai T; Matsumoto Y; Shimozato K; Kozaki K
Immunology; 2005 Sep; 116(1):53-63. PubMed ID: 16108817
[TBL] [Abstract][Full Text] [Related]
19. Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis.
Daniels T; Zhang J; Gutierrez I; Elliot ML; Yamada B; Heeb MJ; Sheets SM; Wu X; Casiano CA
Prostate; 2005 Jan; 62(1):14-26. PubMed ID: 15389814
[TBL] [Abstract][Full Text] [Related]
20. Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours.
Chang SC; Yuan SH; Li CY; Chang HM; Wang HC; Pan YA; Hsueh PC; Wu CC; Yang Y; Liu HP
Vet Comp Oncol; 2021 Mar; 19(1):172-182. PubMed ID: 33038064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
